Immunocore Holdings (IMCR) Payables: 2022-2025
Historic Payables for Immunocore Holdings (IMCR) over the last 2 years, with Sep 2025 value amounting to $23.0 million.
- Immunocore Holdings' Payables fell 66.21% to $23.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $101.0 million, marking a year-over-year decrease of 16.63%. This contributed to the annual value of $25.1 million for FY2024, which is 41.03% up from last year.
- According to the latest figures from Q3 2025, Immunocore Holdings' Payables is $23.0 million, which was down 3.77% from $23.9 million recorded in Q2 2025.
- In the past 5 years, Immunocore Holdings' Payables ranged from a high of $67.9 million in Q3 2024 and a low of $14.4 million during Q4 2022.
- Moreover, its 3-year median value for Payables was $23.4 million (2025), whereas its average is $27.8 million.
- Within the past 5 years, the most significant YoY rise in Immunocore Holdings' Payables was 87.76% (2025), while the steepest drop was 66.21% (2025).
- Over the past 4 years, Immunocore Holdings' Payables (Quarterly) stood at $14.4 million in 2022, then grew by 23.17% to $17.8 million in 2023, then surged by 41.03% to $25.1 million in 2024, then slumped by 66.21% to $23.0 million in 2025.
- Its last three reported values are $23.0 million in Q3 2025, $23.9 million for Q2 2025, and $29.1 million during Q1 2025.